Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.